Seegene Inc - Company Profile
Powered by 
All the sales intelligence you need on Seegene Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Seegene Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Seegene Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Seegene Inc (Seegene) is a pharmaceutical company that manufacturer manufactures in vitro diagnostic products, particularly molecular diagnostics. The company carries out the development and provision of diagnostic assays and technologies for detecting various infectious diseases. Its offers product in various therapy areas such as respiratory infections, gastrointestinal tract infections, sexually transmitted infections, human papillomavirus infections, tuberculosis, sepsis and meningitis, among others. Seegene's markets its products under the brands Seegene STARlet-AIOS, SEEPREP32, CFX96, MUDT, TOCE, DPO, Novaplex, Anyplex, and Allplex. The company operates in Asia, Europe, Africa and America. Seegene is headquartered in Seoul, South Korea.
Headquarters
South Korea
Address
Taewon Bldg., 91, Ogeum-Ro, Songpa-Gu, Seoul, 05548
Website
www.seegene.com
Telephone
82 2 22404000
No of Employees
822
Industry
Medical Equipment
Ticker Symbol & Exchange
096530 (KDQ)
Revenue (2024)
$333.7M
14.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
651.1%
(2024 vs 2023)
Market Cap*
$976.5M
Net Profit Margin (2024)
XYZ
582.5%
(2024 vs 2023)
* As of and is in US$
Seegene Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Assays: | Seegene STARlet-AIOS |
| Respiratory Infection: | SEEPREP32 |
| Allplex RV Master Assay | CFX96 |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In December, the company opened a new subsidiary in France. |
| 2025 | New Products/Services | In April, the company launched CURECA, a next-gen lab automation system. |
| 2025 | Contracts/Agreements | In February, the company signed an agreement to acquire Dandi Mecca, an automated equipment development company. |
Competitor Comparison
| Key Parameters | Seegene Inc | Samil Pharmaceutical Co Ltd | Hyundai Bioland Co Ltd | Curexo Inc | Seoul Pharma Co Ltd |
|---|---|---|---|---|---|
| Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
| City | Seoul | Seoul | Cheongju | Seoul | Cheongju |
| State/Province | Seoul | Seoul | - | Seoul | - |
| No. of Employees | 822 | 395 | 342 | 99 | 133 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Cheon Jong Yon | Representative Director; Chief Executive Officer | Senior Management | - | - |
| Lee Dae Hoon | Representative Director | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer